AzTrials
AzTrials

Aortic Root AneurysmAORTLANTICNCT05515848

Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David

An observational study of Aortic Root Aneurysm and Aortic Regurgitation, run by Nantes University Hospital at 5 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at six centers (Nantes - Rennes - Brest - Angers - Tours [two centers]). Read more about this study

Who is it for?
Any age
Conditions the study is for
Aortic Root Aneurysm, Aortic Regurgitation
How many people
529 participants
Where
5 sitesFrance
Study dates
7 Nov 2021to 31 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2021, at five centers (Nantes, Rennes, Brest, Angers,Tours UH) .

Who may be able to join

  • Patients undergoing aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2021, at one of the six centers: Nantes, Rennes, Brest, Angers,Tours UH.
  • Non inclusion criteria :
  • Prosthetic replacement of the aortic valve intraoperatively during the first operation.

Who cannot join

None listed.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

France5 sites
  • CHU d'Angers

    Angers

  • CHU de Brest

    Brest

  • Nantes University Hospital

    Nantes

  • CHU de Rennes

    Rennes

  • CHU de Tours

    Tours

Other trials in France

About this study

Official title: Regional, Multicentric Registry of Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David

Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at six centers (Nantes - Rennes - Brest - Angers - Tours [two centers]). The main objective of this study is to evaluate the survival without re-intervention for aortic valve dysfunction (surgery or TAVI).

Read the detailed description

Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David.

Inclusion criteria: Patients undergoing aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at one of the six centers: Nantes, Rennes, Brest, Angers, Tours (two centers).

Non-inclusion criteria: Prosthetic replacement of the aortic valve intraoperatively during the first operation.

Objectives and endpoints :

  • The survival without re-intervention for aortic valve dysfunction (surgery or TAVI)
  • The overall cardiovascular survival
  • The survival without aortic insufficiency of grade equal to or greater than two
  • The survival without aortic infective endocarditis
  • Assessment of long-term stroke risk Assessment of the risk of a major bleeding event in the long term Data analysis : The AORTLANTIC study is included in the EPICARD registry which is the official, national database of the French Society of Cardiac Surgery. Study data will then be collected using EPICARD's electronic Case Report Form (eCRF) and then analyzed using a multivariate Cox model. For the follow-up, the WEPI eCRF is used.
Being tested
No intervention
Keywords
Valve-sparing aortic root replacement, David procedure, Acute aortic dissection, Aortic Regurgitation, Bicuspid aortic valve, French multicentric registry
Medical subject headings
Aortic Root Aneurysm, Aortic Valve Insufficiency, Bicuspid Aortic Valve Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    There is no intervention in this retrospective study.

Study groups in NCT05515848
Study groupRoleWhat they receive
AORTLANTIC registryPatients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2021, at five centers (Nantes - Rennes - Brest - Angers - Tours University Hospital (UH))
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the survival without re-intervention for aortic valve dysfunction (surgery or TAVI), after aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David

    Number of patients alive without re-intervention for aortic valve dysfunction (surgery or TAVI)

    Measured: Conditional survival starting at 30 days

Secondary outcomes (5)
  1. Evaluate the overall cardiovascular survival results

    Number of patients alive

    Measured: up to 17 months

  2. Evaluate the absence of aortic insufficiency greater than or equal to grade two between the two types of aortic tube graft (right prosthesis or Valsalva prosthesis)

    Number of patients alive without aortic insufficiency of grade equal to or greater than two

    Measured: up to 17 months

  3. Evaluate the risk of infective endocarditis

    Number of patients alive without aortic infective endocarditis

    Measured: up to 17 months

  4. Evaluate the risk of stroke

    Number of patients alive without stroke

    Measured: up to 17 months

  5. Evaluate the risk of major bleeding event

    Number of patients alive major bleeding event

    Measured: up to 17 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2022
  2. Study start7 Nov 2021
  3. Primary completion31 Jul 2023
  4. Study completion31 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
529 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05515848
Sponsor's protocol ID
RC21_0540
Acronym
AORTLANTIC
Status last verified
Aug 2023
First submitted
18 Aug 2022
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Aortic Root Aneurysm and Aortic Regurgitation, run by Nantes University Hospital at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the survival without re-intervention for aortic valve dysfunction (surgery or TAVI), after aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David (time frame: Conditional survival starting at 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in